45 series
Export
<<< of 3>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterExpression profiling by high throughput sequencing Remove filterFeb 19, 2024
GSE167469
PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
  • Expression profiling by high throughput sequencing
2 Yizhe Sun Feb 19, 2024
GSE168862
PTIR1 acts as a suppressor of immunoproteasome and promotes cancer immune resistance
  • Expression profiling by high throughput sequencing
2 Jia Song Feb 19, 2024
GSE192632
NAP-seq Reveals Novel Classes of Structured Noncoding RNAs with Regulatory Functions
  • Expression profiling by high throughput sequencing
32 Jian-Hua Yang Feb 19, 2024
GSE197798
Human antigen R (HuR) SUMOylation controls senescence response in liver cancer
  • Expression profiling by high throughput sequencing
12 Supriyo De Feb 19, 2024
GSE210684
RNA-seq of wild-type and Ptenα-/- MEFs under VSV infection
  • Expression profiling by high throughput sequencing
4 Zeliang Yang Feb 19, 2024
GSE218439
UV cross-linking RIP-seq of VSV-GFP-infected HEK293T cells overexpressed PTENα
  • Expression profiling by high throughput sequencing
2 Zeliang Yang Feb 19, 2024
GSE224465
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [RNA-Seq]
  • Expression profiling by high throughput sequencing
53 Christopher Russell Chin Feb 19, 2024
GSE224513
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas.
143 Christopher Russell Chin Feb 19, 2024
GSE224782
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas (scRNA-Seq)
  • Expression profiling by high throughput sequencing
4 Christopher Russell Chin Feb 19, 2024
GSE225610
ARID1A governs silencing of sex-linked transcription during male meiosis in the mouse [RNA-seq]
  • Expression profiling by high throughput sequencing
8 Terry Magnuson Feb 19, 2024
GSE225612
ARID1A governs silencing of sex-linked transcription during male meiosis in the mouse.
33 Terry Magnuson Feb 19, 2024
GSE227064
Lipocalin-2 expression identifies an immuno-regulatory intestinal neutrophil population during GVHD
  • Expression profiling by high throughput sequencing
22 Nina Peltokangas Feb 19, 2024
GSE227976
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma
11 Lixin Rui Feb 19, 2024
GSE228007
Primate-expressed EPIREGULIN promotes basal progenitor proliferation in the developing neocortex
  • Expression profiling by high throughput sequencing
18 Mareike Albert Feb 19, 2024
GSE228168
Full-length Sequencing of Non-capped RNAs Reveals the Heterogeneity of RNA Processing and Novel Classes of Noncoding RNAs
  • Expression profiling by high throughput sequencing
26 Jian-Hua Yang Feb 19, 2024
GSE229940
Radiotherapy induces persistent innate immune reprogramming of microglia into a priming state
  • Expression profiling by high throughput sequencing
16 Takuya Oshima Feb 19, 2024
GSE230331
Single cell RNA-seq analysis for spleen tissue under steady state, phenohydrazine (PHZ) and bleeding treatment.
  • Expression profiling by high throughput sequencing
4 Rui Yokomori Feb 19, 2024
GSE231774
Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development
  • Expression profiling by high throughput sequencing
36 Christian Mayer Feb 19, 2024
GSE231779
Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development
38 Christian Mayer Feb 19, 2024
GSE233226
Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons
  • Expression profiling by high throughput sequencing
9 Shusaku Uchida Feb 19, 2024